These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12843747)

  • 1. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users.
    Strasfeld L; Lo Y; Netski D; Thomas DL; Klein RS
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):356-64. PubMed ID: 12843747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV genotype analysis in HCV-HIV-co-infected Puerto Ricans who are injecting drug users: undetermined and mixed infections.
    Ríos-Olivares E; Yamamura Y; Gómez MA; Guzmán L; Rodríguez N; Fernández D; Hunter Mellado R
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1017-24. PubMed ID: 11785651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.
    Peters L; Mocroft A; Soriano V; Rockstroh JK; Kirkby N; Reiss P; Katlama C; Zakharova N; Flisiak R; Lundgren JD;
    HIV Med; 2014 Nov; 15(10):615-20. PubMed ID: 24814468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
    Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
    J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic variants of hepatitis C virus in HIV-infected drug users].
    Bobkova MR; Samokhvalov EI; Kravchenko AV; Salamov GG; Zverev SIa; Pokrovskiĭ VV; L'vov DK
    Vopr Virusol; 2002; 47(3):15-20. PubMed ID: 12173428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand.
    Ngo-Giang-Huong N; Jourdain G; Sirirungsi W; Decker L; Khamduang W; Le Coeur S; Sirinontakan S; Somsamai R; Pagdi K; Hemvuttiphan J; McIntosh K; Barin F; Lallemant M
    Int J Infect Dis; 2010 Jul; 14(7):e602-7. PubMed ID: 20047847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.
    Hsieh MH; Tsai JJ; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Yu ML; Chuang WL
    PLoS One; 2014; 9(4):e94791. PubMed ID: 24722534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter evaluation of hepatitis C RNA levels among female injection drug users.
    Thomas DL; Rich JD; Schuman P; Smith DK; Astemborski JA; Nolt KR; Klein RS
    J Infect Dis; 2001 Mar; 183(6):973-6. PubMed ID: 11237816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
    Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
    J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
    Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
    J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
    Matheï C; Buntinx F; Van Damme P
    J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
    [No Abstract]   [Full Text] [Related]  

  • 14. Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.
    Rauch A; Gaudieri S; Evison J; Nolan D; Cavassini M; Weber R; James I; Furrer H;
    Antivir Ther; 2008; 13(3):455-60. PubMed ID: 18572759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.
    Seal KH; Monto A; Dove L; Shen H; Vittinghoff E; Tracy D; Miller E; Lau E; Wright TL
    Dig Dis Sci; 2007 Dec; 52(12):3423-30. PubMed ID: 17443407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam.
    Nguyen TT; Lemee V; Bollore K; Vu HV; Lacombe K; Thi XLT; Luong QA; Dubos C; Plantier JC; Thi HD; Laureillard D; Lemoine M; Tuaillon E
    BMC Infect Dis; 2018 Dec; 18(1):622. PubMed ID: 30514229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.
    Uccellini L; Tseng FC; Monaco A; Shebl FM; Pfeiffer R; Dotrang M; Buckett D; Busch MP; Wang E; Edlin BR; Marincola FM; O'Brien TR
    Hepatology; 2012 Jul; 56(1):86-94. PubMed ID: 22331649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.
    Berger A; von Depka Prondzinski M; Doerr HW; Rabenau H; Weber B
    J Med Virol; 1996 Apr; 48(4):339-43. PubMed ID: 8699166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.